50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

Cantor Fitzgerald cuts Lucid Diagnostics stock target to $3 from $3.80

Published 03/26/2024, 05:32 PM
Updated 03/26/2024, 08:35 PM
LCID
-

On Tuesday, Cantor Fitzgerald adjusted its stock price target for Lucid (NASDAQ:LCID) Diagnostics (NASDAQ:LCUD), lowering it to $3.00 from the previous $3.80. Despite the reduction, the firm maintained its Overweight rating on the company's shares. The revision follows Lucid Diagnostics' announcement of its fourth-quarter 2023 operating results and corporate updates.

Lucid Diagnostics reported a fourth-quarter revenue of $1.0 million, which was above the FactSet consensus estimate of $0.8 million but below Cantor Fitzgerald's expectation of $1.2 million. The company experienced a 15% sequential decrease in volumes, although there was an 87% year-over-year increase to 2,201 tests. This growth was attributed to Lucid's satellite testing activity and firefighter events.

The firm emphasized the positive impact of Lucid's second-quarter revenue cycle management upgrade. This upgrade has led to better allowed claims percentages and average allowed payments, which are expected to continue improving towards the company's Medicare payment rate. With these enhancements in the revenue cycle, Lucid is anticipated to see better collections and payments moving forward.

Cantor Fitzgerald reiterated its Overweight rating on Lucid Diagnostics' shares, citing the expectation of accelerating volumes and improved financial metrics. The firm's analysis suggests that these factors, along with the revenue cycle management upgrade, provide a solid foundation for Lucid's future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.